![Roger Garceau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Roger Garceau
Direktor/Vorstandsmitglied bei ENTERA BIO LTD.
Vermögen: 103 845 $ am 31.05.2024
Aktive Positionen von Roger Garceau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENTERA BIO LTD. | Direktor/Vorstandsmitglied | 01.03.2016 | - |
Vorstandsvorsitzender | 10.08.2020 | 04.01.2021 | |
PROTARA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Independent Dir/Board Member | 01.01.2019 | - | |
Fluorinov Pharmaceuticals, Inc.
![]() Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Direktor/Vorstandsmitglied | 04.05.2015 | - |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | 01.12.2016 | - |
Independent Dir/Board Member | 01.12.2016 | - |
Karriereverlauf von Roger Garceau
Ehemalige bekannte Positionen von Roger Garceau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NPS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.06.2009 | 01.02.2015 |
Vertrieb & Marketing | 11.12.2008 | 11.06.2009 | |
ArTara Subsidiary, Inc.
![]() ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | 01.01.2019 | - |
Ausbildung von Roger Garceau
Fairfield University | Undergraduate Degree |
UMass Chan Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Frankreich | 2 |
Israel | 2 |
Operativ
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ENTERA BIO LTD. | Health Technology |
PROTARA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
NPS Pharmaceuticals, Inc.
![]() NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Fluorinov Pharmaceuticals, Inc.
![]() Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Health Technology |
Enterome SA
![]() Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
ArTara Subsidiary, Inc.
![]() ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Roger Garceau
- Erfahrung